HCV core antigen as an alternate test to HCV RNA for assessment of virologic responses to all-oral, interferon-free treatment in HCV genotype 1 infected patients.

[1]  A. Aghemo,et al.  Quantification of Core Antigen Monitors Efficacy of Direct-acting Antiviral Agents in Patients With Chronic Hepatitis C Virus Infection. , 2016, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[2]  J. M. Freiman,et al.  Hepatitis C Core Antigen Testing for Diagnosis of Hepatitis C Virus Infection , 2016, Annals of Internal Medicine.

[3]  J. Pawlotsky,et al.  Clinical Utility of HCV Core Antigen Detection and Quantification in the Diagnosis and Management of Patients with Chronic Hepatitis C Receiving an All-Oral, Interferon-Free Regimen , 2016, Antiviral therapy.

[4]  C. Galli,et al.  Evolving strategy for HCV testing in an Italian tertiary care hospital. , 2016, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[5]  J. Ward,et al.  Simple, Effective, but Out of Reach? Public Health Implications of HCV Drugs. , 2015, The New England journal of medicine.

[6]  Cicioğlu Arıdoğan Buket,et al.  Comparison of HCV core antigen and anti-HCV with HCV RNA results. , 2015, African health sciences.

[7]  K. Reddy,et al.  Concordance of sustained virological response 4, 12, and 24 weeks post‐treatment with sofosbuvir‐containing regimens for hepatitis C virus , 2015, Hepatology.

[8]  H. Razavi,et al.  Global epidemiology and genotype distribution of the hepatitis C virus infection. , 2014, Journal of hepatology.

[9]  F. Lehner,et al.  Hepatitis C virus core antigen testing in liver and kidney transplant recipients , 2014, Journal of viral hepatitis.

[10]  J. Pawlotsky,et al.  Clinical utility of hepatitis C virus core antigen quantification in patients with chronic hepatitis C. , 2014, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[11]  M. Weinstein,et al.  The Hepatitis C Cascade of Care: Identifying Priorities to Improve Clinical Outcomes , 2014, PloS one.

[12]  M. Capobianchi,et al.  HCV core antigen and HCV-RNA in HIV/HCV co-infected patients with different HCV genotypes , 2014, BMC Infectious Diseases.

[13]  T. Pilot‐Matias,et al.  Phase 2b trial of interferon-free therapy for hepatitis C virus genotype 1. , 2014, The New England journal of medicine.

[14]  A. Huber,et al.  Detection limit of architect hepatitis C core antigen assay in correlation with HCV RNA, and renewed confirmation algorithm for reactive anti-HCV samples. , 2013, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[15]  A. Georgiou,et al.  Is HCV core antigen a reliable marker of viral load? An evaluation of HCV core antigen automated immunoassay , 2013, Annals of gastroenterology.

[16]  R. Tedder,et al.  Therapy‐induced clearance of HCV core antigen from plasma predicts an end of treatment viral response , 2013, Journal of viral hepatitis.

[17]  A. Berger,et al.  Clinical utility of the ARCHITECT HCV Ag assay for early treatment monitoring in patients with chronic hepatitis C genotype 1 infection. , 2012, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[18]  H. Wedemeyer,et al.  Natural history of acute and chronic hepatitis C. , 2012, Best practice & research. Clinical gastroenterology.

[19]  M. Manns,et al.  HCV core antigen testing in HIV- and HBV-coinfected patients, and in HCV-infected patients on hemodialysis. , 2012, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[20]  Y. Uyar,et al.  Comparison of a Newly Developed Automated and Quantitative Hepatitis C Virus (HCV) Core Antigen Test with the HCV RNA Assay for Clinical Usefulness in Confirming Anti-HCV Results , 2011, Journal of Clinical Microbiology.

[21]  C. Galli,et al.  Hepatitis C virus core antigen: analytical performances, correlation with viremia and potential applications of a quantitative, automated immunoassay. , 2011, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[22]  J. Karakaya,et al.  Utility of a commercial quantitative hepatitis C virus core antigen assay in a diagnostic laboratory setting. , 2011, Diagnostic microbiology and infectious disease.

[23]  Hyon-Suk Kim,et al.  New Automated Hepatitis C Virus (HCV) Core Antigen Assay as an Alternative to Real-Time PCR for HCV RNA Quantification , 2010, Journal of Clinical Microbiology.

[24]  G. Gerken,et al.  Analytical Performance Characteristics and Clinical Utility of a Novel Assay for Total Hepatitis C Virus Core Antigen Quantification , 2010, Journal of Clinical Microbiology.

[25]  M. Manns,et al.  Performance and clinical utility of a novel fully automated quantitative HCV-core antigen assay. , 2009, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[26]  H. Saegusa,et al.  A new sensitive and automated chemiluminescent microparticle immunoassay for quantitative determination of hepatitis C virus core antigen. , 2009, Journal of virological methods.

[27]  D. Lavanchy,et al.  The global burden of hepatitis C , 2009, Liver international : official journal of the International Association for the Study of the Liver.

[28]  A. Neumann,et al.  Clinical utility of total HCV core antigen quantification: A new indirect marker of HCV replication , 2002, Hepatology.

[29]  K. Kadkhoda,et al.  HCV antigen testing for the diagnosis of hepatitis C infection: a cost-efficient algorithm. , 2014, Clinical laboratory.